The NG2/CSPG4 immunoreactivity is diffusely detectable in >75% of anaplastic IDH-mutant/1p19q-codel oligodendrogliomas and in >40% of IDH-wild type GBs. The gene discussed is CSPG4; the disease is oligodendroglioma.